Penicillin-Susceptible

Streptococcus pneumoniae ceftriaxone cerebrospinal fluid meningitis penicillin

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
09 May 2023
Historique:
received: 23 04 2023
revised: 04 05 2023
accepted: 04 05 2023
medline: 27 5 2023
pubmed: 27 5 2023
entrez: 27 5 2023
Statut: epublish

Résumé

The recommended empiric ceftriaxone dosing regimen for acute bacterial meningitis in adults is 2 g every 12 h. After penicillin-susceptible

Identifiants

pubmed: 37237781
pii: antibiotics12050878
doi: 10.3390/antibiotics12050878
pmc: PMC10215215
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NIAID NIH HHS
ID : K23 AI143882
Pays : United States

Références

Clin Pharmacokinet. 2001;40(9):685-94
pubmed: 11605716
J Antimicrob Chemother. 2019 Jun 1;74(6):1753-1755
pubmed: 30793755
Brain. 2003 May;126(Pt 5):1015-25
pubmed: 12690042
Lancet Neurol. 2006 Feb;5(2):123-9
pubmed: 16426988
Antimicrob Agents Chemother. 2022 Jun 21;66(6):e0218921
pubmed: 35575578
Clin Pharmacokinet. 2000 Nov;39(5):335-43
pubmed: 11108433
Intensive Care Med. 2020 Jun;46(6):1127-1153
pubmed: 32383061
Clin Infect Dis. 1995 May;20(5):1164-8
pubmed: 7619994
Lancet Neurol. 2006 Apr;5(4):332-42
pubmed: 16545750
J Antimicrob Chemother. 1984 Oct;14(4):427-30
pubmed: 6094424
Int J Antimicrob Agents. 2003 May;21(5):452-6
pubmed: 12727079
Euro Surveill. 2016 May 26;21(21):
pubmed: 27254535
J Infect Dis. 2002 Oct 1;186(7):1047-52
pubmed: 12232850
Xenobiotica. 1987 Oct;17(10):1139-45
pubmed: 3424863
Klin Mikrobiol Infekc Lek. 2010 Apr;16(2):64-72
pubmed: 20503158
Lancet Infect Dis. 2014 Sep;14(9):805-12
pubmed: 25104306
J Pharmacol Exp Ther. 1986 Feb;236(2):380-3
pubmed: 3080583
Ann Neurol. 2006 Oct;60(4):456-68
pubmed: 16958121
Diagn Microbiol Infect Dis. 2007 Aug;58(4):445-52
pubmed: 17512154
Nat Rev Dis Primers. 2016 Nov 03;2:16074
pubmed: 27808261
N Engl J Med. 2004 Oct 28;351(18):1849-59
pubmed: 15509818
Clin Microbiol Infect. 2016 May;22 Suppl 3:S37-62
pubmed: 27062097
S Afr Med J. 2013 Sep 03;103(12):906-9
pubmed: 24300626
Clin Microbiol Rev. 2011 Jul;24(3):557-91
pubmed: 21734248
Antimicrob Agents Chemother. 1982 Nov;22(5):816-23
pubmed: 6295268
Lancet. 2017 Dec 17;388(10063):3036-3047
pubmed: 27265346
Br J Clin Pharmacol. 2015 Sep;80(3):525-33
pubmed: 25808018
Clin Microbiol Rev. 2010 Oct;23(4):858-83
pubmed: 20930076
Med Princ Pract. 2008;17(1):76-9
pubmed: 18059106
Antimicrob Agents Chemother. 2019 Aug 23;63(9):
pubmed: 31235630

Auteurs

Samuel Raemy (S)

Institute for Infectious Diseases, University of Bern, 3001 Bern, Switzerland.

Carlo Casanova (C)

Institute for Infectious Diseases, University of Bern, 3001 Bern, Switzerland.

Rossella Baldan (R)

Institute for Infectious Diseases, University of Bern, 3001 Bern, Switzerland.

Erin Barreto (E)

Department of Pharmacy, Mayo Clinic, Rochester, MN 55902, USA.

Aaron J Tande (AJ)

Division of Public Health, Infectious Diseases and Occupational Medicine, Department of Medicine, Mayo Clinic, Rochester, MN 55902, USA.

Andrea Endimiani (A)

Institute for Infectious Diseases, University of Bern, 3001 Bern, Switzerland.

Stephen L Leib (SL)

Institute for Infectious Diseases, University of Bern, 3001 Bern, Switzerland.

Urs Fischer (U)

Department of Neurology, University Hospital Bern, University of Bern, 3010 Bern, Switzerland.
Department of Neurology, University Hospital Basel, University of Basel, 4001 Basel, Switzerland.

Parham Sendi (P)

Institute for Infectious Diseases, University of Bern, 3001 Bern, Switzerland.

Classifications MeSH